Skip to content

The Incidence of the Intravascular Injection During S1 Transforaminal Epidural Steroid Injection in Two Approaches: Anteroposterior Versus Oblique

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01926470
Enrollment
201
Registered
2013-08-21
Start date
2013-07-31
Completion date
2014-07-31
Last updated
2014-07-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbosacral Radicular Pain

Keywords

epidural injections, intravascular injection

Brief summary

Lumbosacral transforaminal epidural steroid injection (TFESI) is helpful for the treatment of lumbosacral radicular pain, but in case of intravascular injection, infrequently serious complication can be developed. Against this backdrop, if there is any difference of frequency of intravascular injection incidence during S1 TFESI between method in anteroposterior view and method in oblique view using Scotty dog, the result can be crucial factor in selecting the approach. In addition, appropriate volume of injection will be checked in each approach.

Interventions

PROCEDUREanteroposterior approach group

anteroposterior approach group (n=104): check intravascular injection while performing S1 transforaminal epidural steroid injection in anteroposterior view under fluoroscopy

PROCEDUREoblique approach group

oblique approach group (n=104): same as anteroposterior approach group except using oblique view

Sponsors

Yonsei University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
SINGLE (Caregiver)

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Adult patients (20-80 years of age) who were scheduled to receive S1 transforaminal epidural steroid injection for lumbosacral radicular pain at our pain management clinic

Exclusion criteria

* pregnancy * coagulopathy * systemic infection * any active infection at the injection site * history of allergy to contrast media, local anesthetics, corticosteroid * patients unable to communicate or patients with cognitive dysfunction

Design outcomes

Primary

MeasureTime frameDescription
the incidence of intravascular injection5 seconds after injection of contrast media via block needle.the incidence of intravascular injection in the anteroposterior approach group and the oblique approach group

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026